What products are used?

 SODIUM CHLORIDE ® 0.9% or physiological saline
– Ion rebalancing thanks to sodium chloride
– Extracellular rehydration
– Vehicle for therapeutic molecules

Water improves cellular therapeutic exchanges (“extra-cellular hydration” or therapeutic cell washing, also known as “Wash-Out”). Water represents 70% of the composition of cells.

Saline is used within the strict framework of its Market Authorization. Quantiatively, it is the main injectable component.

XYLOCAINE ® at 1% without adrenaline or PROCAINE ®
– For locoregional anaesthesia

These products are also used in the line with their Market Authorization.

Widely used in mesotherapy to achieve slight local numbing to improve patient comfort. It should be noted that Procaine has a vasodilatory and entropy regeneration effect (work by Prof Aslan).

TRACE ELEMENTS   (Zinc, Copper, Manganese, Fluorine, Iodine, Potassium, Selenium, Iron, etc.).

Water-soluble B-group VITAMINS SOLUVIT® Vitamins B1, B2, B3, B5, B6, B9, B12 (if the patient has a history of cancer, vitamin B12 is omitted). Used for their regenerating and neurotropic properties.

Fat-soluble A D C E K VITAMINS VITALIPIDE®. Used for their trophic, healing, anti-oxidant, anti-radical effects, among others.

MAGNESIUM MAGINJECTABLE®. Used for its role in the quality of neuromuscular transmission.

ORAGNIC SILICA CONJONCTYL ®. A regenerator of conjunctive tissues and collagen. For repair of the extracellular matrix.

AMINO ACIDS, PERIKABIVEN® or VAMINOLACT® (Alanine, Arginine, Leucine, Methionine, Valine)
A veritable genomic and metabolic therapy acting through protein synthesis.

VASODILATORS to improve micro-circulation (rheological effect), are of particular interest when treating degenerative phenomena (osteoarthritis).

ANTI-INFLAMMATORIES can be used at low doses for their “ASPIRIN-LIKE” effects on platelet aggregation (i.e. blood thinner), to optimise microcirculation for regeneration needs.

E.D.T.A. (Pharmaceutical preparation of Ethyl-Diamino-Tetra-Acetic acid, from Germany and the Netherlands), a chelator for heavy metals and bone calcium from the peripheral skeleton, which play essential roles in osteoarthritis. Known since 1980 in mesotherapy (Dalloz and Bourguignon), where it has produced spectacular results on calcific periarthritis of the shoulder. EDTA acts mainly on peripheral bone condensation (osteophytosis or cervical bone spurs), which is the main mechanical cause of the osteoarthritic process. In this process, calcium from the bone’s periphery is displaced, creating permanent, painful bone contacts associated with inflammation in the joints. The inflammation then acts directly on the bone expansion process, leading to destruction of the cartilage in the joint or the intervertebral disc, and reducing the vertebral foramen with effects on the nerve roots (e.g. cervicobrachial neuralgia, sciatica, discopathy). The use of EDTA thus introduces the new concept of MESOCHELATION “Very small amounts, rarely and in the right place” (Dr Pistor).

VACCINES: anti-influenza, anti-pneumococcus, anti-haemophilus type B (in France); polyvalent injectable homeopathic vaccines (in Switzerland and Germany).